Skip to content
About
Company Overview
Board of Directors
Management Team
Organization Chart
R&D
Pipeline
Pipeline Overview
Globo H
Adagloxad simolenin
(Vaccine)
OBI-833
(Vaccine)
AKR1C3
OBI-3424
(Prodrug)
TROP2
OBI-992
(ADC)
OBI-902
(ADC)
Nectin4
OBI-904
(ADC)
HER2
OBI-905
(ADC)
Technology Platform
Reference Library
News
Investors
Investor Overview
About
Company Profile
Corporate Governance
Stakeholder
News&Events
Announcements
Event Calendar
Financial Information
Annual Report
Financial Report
Monthly Revenues
Stock Quote
IR Presentation
Careers
ESG
Contact
繁體中文
About
Company Overview
Board of Directors
Management Team
Organization Chart
R&D
Pipeline
Pipeline Overview
Globo H
Adagloxad simolenin
(Vaccine)
OBI-833
(Vaccine)
AKR1C3
OBI-3424
(Prodrug)
TROP2
OBI-992
(ADC)
OBI-902
(ADC)
Nectin4
OBI-904
(ADC)
HER2
OBI-905
(ADC)
Technology Platform
Reference Library
News
Investors
Investor Overview
About
Company Profile
Corporate Governance
Stakeholder
News&Events
Announcements
Event Calendar
Financial Information
Annual Report
Financial Report
Monthly Revenues
Stock Quote
IR Presentation
Careers
ESG
Contact
繁體中文
2014-12-08
Cancer Active Immunotherapy OBI-822 Mechanelism Action
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our
use of cookies
.
Cookie Settings
Accept
Manage consent
Close
必要性
必要性
Always Enabled
必要性cookies在網站內是絕對重要的功能, 此分類僅包含功能性及安全性的cookies, 此cookies不會存取任何個人隱私資料。
非必要性
非必要性
任何對於網站潛在必要性的cookies已經使用, 非必要性則為收集個資, 數據, 廣告置入等..